{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:35:17Z","timestamp":1791999317883,"version":"4.4.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004350","name":"German National Merit Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["25,27"],"award-info":[{"award-number":["25,27"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.tips.2025.05.001","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T16:09:45Z","timestamp":1750435785000},"page":"610-628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["GPR17 \u2013 orphan G protein-coupled receptor with therapeutic potential"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1383-4745","authenticated-orcid":false,"given":"Michael","family":"Lewash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8284-5514","authenticated-orcid":false,"given":"Evi","family":"Kostenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-6624","authenticated-orcid":false,"given":"Christa E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2025.05.001_bb0005","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nn.2410","article-title":"The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination","volume":"12","author":"Chen","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2025.05.001_bb0010","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/jcmm.12305","article-title":"Expression of dual nucleotides\/cysteinyl-leukotrienes receptor GPR17 in early trafficking of cardiac stromal cells after myocardial infarction","volume":"18","author":"Cosentino","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.tips.2025.05.001_bb0015","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1038\/s41598-018-22452-0","article-title":"G-protein-coupled receptor Gpr17 regulates oligodendrocyte differentiation in response to lysolecithin-induced demyelination","volume":"8","author":"Lu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2025.05.001_bb0020","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s12035-018-1146-1","article-title":"G-protein-coupled receptor Gpr17 expression in two multiple sclerosis remyelination models","volume":"56","author":"Nyamoya","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tips.2025.05.001_bb0025","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.3390\/ijms22094574","article-title":"The distribution of GPR17-expressing cells correlates with white matter inflammation status in brain tissues of multiple sclerosis patients","volume":"22","author":"Angelini","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2025.05.001_bb0030","doi-asserted-by":"crossref","first-page":"7314","DOI":"10.1080\/21655979.2021.1979352","article-title":"Knockdown of G protein-coupled receptor-17 (GPR17) facilitates the regeneration and repair of myelin sheath post-periventricular leukomalacia (PVL)","volume":"12","author":"He","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.tips.2025.05.001_bb0035","article-title":"Therapeutic advances in multiple sclerosis","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tips.2025.05.001_bb0040","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.tips.2025.05.001_bb0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2025.05.001_bb0050","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1038\/sj.emboj.7601341","article-title":"The orphan receptor GPR17 identified as a new dual uracil nucleotides\/cysteinyl-leukotrienes receptor","volume":"25","author":"Ciana","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.tips.2025.05.001_bb0055","doi-asserted-by":"crossref","first-page":"11685","DOI":"10.1073\/pnas.0905364106","article-title":"GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4","volume":"106","author":"Maekawa","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2025.05.001_bb0060","doi-asserted-by":"crossref","first-page":"ra93","DOI":"10.1126\/scisignal.2004350","article-title":"Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist","volume":"6","author":"Hennen","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.tips.2025.05.001_bb0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1124\/jpet.113.207647","article-title":"Is GPR17 a P2Y\/leukotriene receptor? Examination of uracil nucleotides, nucleotide sugars, and cysteinyl leukotrienes as agonists of GPR17","volume":"347","author":"Qi","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2025.05.001_bb0070","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1021\/ml400399f","article-title":"Development of (3)H2-Carboxy-4,6-dichloro-1H-indole-3-propionic acid ((3)HPSB-12150): a useful tool for studying GPR17","volume":"5","author":"K\u00f6se","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.tips.2025.05.001_bb0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bph.15969","article-title":"Identification and characterization of select oxysterols as ligands for GPR17","volume":"180","author":"Harrington","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2025.05.001_bb0080","article-title":"Discovery of novel and selective GPR17 antagonists as pharmacological tools for developing new therapeutic strategies in diabetes and obesity","author":"Zhu","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.tips.2025.05.001_bb0085","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10822-011-9455-8","article-title":"In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases","volume":"25","author":"Eberini","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.tips.2025.05.001_bb0090","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.chembiol.2018.03.012","article-title":"Repurposing HAMI3379 to block GPR17 and promote rodent and human oligodendrocyte differentiation","volume":"25","author":"Merten","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.tips.2025.05.001_bb0095","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1523\/JNEUROSCI.4178-07.2008","article-title":"A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function","volume":"28","author":"Cahoy","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2025.05.001_bb0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuroscience.2011.11.066","article-title":"The new P2Y-like receptor G protein-coupled receptor 17 mediates acute neuronal injury and late microgliosis after focal cerebral ischemia in rats","volume":"202","author":"Zhao","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2025.05.001_bb0105","doi-asserted-by":"crossref","first-page":"8136","DOI":"10.1021\/acs.jmedchem.7b01768","article-title":"3-(2-Carboxyethyl)indole-2-carboxylic acid derivatives: structural requirements and properties of potent agonists of the orphan G protein-coupled receptor GPR17","volume":"61","author":"Baqi","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2025.05.001_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111789","article-title":"Design, synthesis and biological evaluation of suramin-derived dual antagonists of the proinflammatory G protein-coupled receptors P2Y2 and GPR17","volume":"186","author":"Pillaiyar","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tips.2025.05.001_bb0115","doi-asserted-by":"crossref","first-page":"19365","DOI":"10.1021\/acs.jmedchem.4c01755","article-title":"Discovery of anthranilic acid derivatives as antagonists of the pro-inflammatory orphan G protein-coupled receptor GPR17","volume":"67","author":"Boshta","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2025.05.001_bb0120","unstructured":"Mueller, C.E. et al. UCB Pharma GmbH. (Aza)indole-, benzothiophene-, and benzofuran-3-sulfonamides, WO 2018\/122232 A1"},{"key":"10.1016\/j.tips.2025.05.001_bb0125","unstructured":"Pegurier, C. et al. UCB Pharma GmbH. Pyridinyl and pyrazinyl-(aza)indolsulfonamides, WO 2019\/243303 A1"},{"key":"10.1016\/j.tips.2025.05.001_bb0130","unstructured":"Pegurier, C. et al. UCB Pharma GmbH. Substituted alkoxypyridinyl indolsulfonamides, WO 2019\/243398 A1"},{"key":"10.1016\/j.tips.2025.05.001_bb0135","unstructured":"Pegurier, C. et al. UCB Pharma GmbH. N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as GPR17 modulators for treating CNS disorders such as multiple sclerosis, WO 2020\/254289 A1"},{"key":"10.1016\/j.tips.2025.05.001_bb0140","unstructured":"Galley, G. et al. Novel pyrimidin-2-yl sulfonamide derivatives, WO 2022\/180136 A1"},{"key":"10.1016\/j.tips.2025.05.001_bb0145","unstructured":"Galley, G. et al. Novel imidazopyridine and pyrazolopyridine sulfonamide derivatives, WO 2024\/017857 A1"},{"key":"10.1016\/j.tips.2025.05.001_bb0150","unstructured":"Galley, G. et al. Novel isoquinolinone, pyrrolopyridinone and thienopyridinone sulfonamide derivatives, WO 2024\/017856 A1"},{"key":"10.1016\/j.tips.2025.05.001_bb0155","unstructured":"Galley, G. et al. Novel isothiazol-3-yl and isoxazol-3-yl sulfonamide compounds, WO 2024\/017855 A1"},{"key":"10.1016\/j.tips.2025.05.001_bb0160","unstructured":"Galley, G. et al. Novel naphthyl and isoquinoline sulfonamide derivatives, WO 2024\/017858 A1"},{"key":"10.1016\/j.tips.2025.05.001_bb0165","unstructured":"Galley, G. et al. Novel pyrimidinyl and triazinyl sulfonamide derivatives, WO 2024\/017863 A1"},{"key":"10.1016\/j.tips.2025.05.001_bb0170","unstructured":"Galley, G. et al. Novel 7-substituted indole sulfonamide derivatives, WO 2024\/023129 A1"},{"key":"10.1016\/j.tips.2025.05.001_bb0175","unstructured":"Galley, G. et al. Novel 7-substituted indole sulfonamide derivatives, WO 2024\/023128 A1"},{"key":"10.1016\/j.tips.2025.05.001_bb0180","unstructured":"Galley, G. et al. Novel deuterated pyrimidin-2-yl sulfonamide derivatives, WO 2024\/042147 A2"},{"key":"10.1016\/j.tips.2025.05.001_bb0185","unstructured":"Pinto, R.M.G.C. et al. Rewind Therapeutics NV. Fused pyrrolyl-sulfonamide compounds, WO 2024\/115733 A1"},{"key":"10.1016\/j.tips.2025.05.001_bb0190","unstructured":"Han, X. et al. Myrobalan Therapeutics Nanjing Co. Ltd. GPR17 modulators and uses thereof, WO 2024\/104462 A1"},{"key":"10.1016\/j.tips.2025.05.001_bb0195","unstructured":"Xi, J. et al. Nanjing Immunophage Biotech Co. Ltd. Compounds and their uses as GPR17 antagonists, WO 2024\/153233 A1"},{"key":"10.1016\/j.tips.2025.05.001_bb0200","unstructured":"Capacci, A. et al. Biogen Ma Inc. [US]. Indole and pyrrolopyridine derivatives as GPR17 modulators, WO 2025\/038863"},{"key":"10.1016\/j.tips.2025.05.001_bb0205","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1038\/ncomms9466","article-title":"Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug","volume":"6","author":"Marschallinger","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2025.05.001_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111683","article-title":"Involvement of GPR17 in neuronal fibre outgrowth","volume":"22","author":"Braune","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2025.05.001_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108335","article-title":"Inhibition of GPR17 with cangrelor improves cognitive impairment and synaptic deficits induced by A\u03b21-42 through Nrf2\/HO-1 and NF-\u03baB signaling pathway in mice","volume":"101","author":"Jin","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tips.2025.05.001_bb0220","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12974-023-02958-9","article-title":"Knockdown and inhibition of hippocampal GPR17 attenuates lipopolysaccharide-induced cognitive impairment in mice","volume":"20","author":"Liang","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tips.2025.05.001_bb0225","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1158\/0008-5472.CAN-11-2632","article-title":"Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma","volume":"72","author":"Dougherty","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2025.05.001_bb0230","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/neuonc\/noaa157","article-title":"Development of a gene expression-based prognostic signature for IDH wild-type glioblastoma","volume":"22","author":"Johnson","year":"2020","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.tips.2025.05.001_bb0235","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1038\/s41467-020-19722-9","article-title":"Polycomb group-mediated histone H2A monoubiquitination in epigenome regulation and nuclear processes","volume":"11","author":"Barbour","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2025.05.001_bb0240","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41419-021-03897-0","article-title":"G-protein-coupled receptor GPR17 inhibits glioma development by increasing polycomb repressive complex 1-mediated ROS production","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tips.2025.05.001_bb0245","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1080\/07391102.2020.1841029","article-title":"Transcriptomic analysis of glioblastoma multiforme providing new insights into GPR17 signaling communication","volume":"40","author":"Mutharasu","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.tips.2025.05.001_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120307","article-title":"GPR17 signaling activation by CHBC agonist induced cell death via modulation of MAPK pathway in glioblastoma","volume":"291","author":"Nguyen","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.tips.2025.05.001_bb0255","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/brain\/awp147","article-title":"The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury","volume":"132","author":"Ceruti","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.tips.2025.05.001_bb0260","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/glia.22929","article-title":"GPR17 expressing NG2-Glia: oligodendrocyte progenitors serving as a reserve pool after injury","volume":"64","author":"Vigan\u00f2","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.tips.2025.05.001_bb0265","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.256","article-title":"The role of oligodendrocyte precursor cells expressing the GPR17 receptor in brain remodeling after stroke","volume":"8","author":"Bonfanti","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tips.2025.05.001_bb0270","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/glia.23305","article-title":"Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination","volume":"66","author":"Coppolino","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.tips.2025.05.001_bb0275","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.neuron.2020.09.016","article-title":"Robust myelination of regenerated axons induced by combined manipulations of GPR17 and microglia","volume":"108","author":"Wang","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2025.05.001_bb0280","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12975-023-01201-0","article-title":"Inhibition of GPR17\/ID2 axis improve remyelination and cognitive recovery after SAH by mediating OPC differentiation in rat model","volume":"16","author":"Wang","year":"2023","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.tips.2025.05.001_bb0285","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/path.6381","article-title":"Characterisation of GPR17-expressing oligodendrocyte precursors in human ischaemic lesions and correlation with reactive glial responses","volume":"265","author":"Raffaele","year":"2025","journal-title":"J. Pathol."},{"key":"10.1016\/j.tips.2025.05.001_bb0290","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.4049\/jimmunol.1001131","article-title":"GPR17 regulates immune pulmonary inflammation induced by house dust mites","volume":"185","author":"Maekawa","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2025.05.001_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.698115","article-title":"Leanness and low plasma leptin in GPR17 knockout mice are dependent on strain and associated with increased energy intake that is not suppressed by exogenous leptin","volume":"12","author":"Wargent","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tips.2025.05.001_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110179","article-title":"Intestinal Gpr17 deficiency improves glucose metabolism by promoting GLP-1 secretion","volume":"38","author":"Yan","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2025.05.001_bb0305","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/biom15010009","article-title":"G protein-coupled receptor 17 inhibits glucagon-like peptide-1 secretion via a Gi\/o-dependent mechanism in enteroendocrine cells","volume":"15","author":"Conley","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.tips.2025.05.001_bb0310","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.159","article-title":"Cryo-EM structure of G-protein-coupled receptor GPR17 in complex with inhibitory G protein","volume":"3","author":"Ye","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.tips.2025.05.001_bb0315","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/jcb.30388","article-title":"Structural analysis of human G-protein-coupled receptor 17 ligand binding sites","volume":"124","author":"Konda Mani","year":"2023","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.tips.2025.05.001_bb0320","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1073\/pnas.041624398","article-title":"Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing","volume":"98","author":"Maekawa","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2025.05.001_bb0325","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1476-5381.2009.00633.x","article-title":"Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants","volume":"159","author":"Benned-Jensen","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2025.05.001_bb0330","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00210-009-0395-y","article-title":"How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs","volume":"379","author":"Michel","year":"2009","journal-title":"Arch. Pharmacol."},{"key":"10.1016\/j.tips.2025.05.001_bb0335","doi-asserted-by":"crossref","DOI":"10.1152\/physiol.2024.39.S1.1524","article-title":"Signaling of GPR17 in hepatic and renal tissues","author":"Spellman","year":"2024","journal-title":"Physiology"},{"key":"10.1016\/j.tips.2025.05.001_bb0340","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00424-021-02544-z","article-title":"Keeping the ageing brain wired: a role for purine signalling in regulating cellular metabolism in oligodendrocyte progenitors","volume":"473","author":"Rivera","year":"2021","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.tips.2025.05.001_bb0345","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/glia.24155","article-title":"Oligodendrogenesis is a key process for cognitive performance improvement induced by voluntary physical activity","volume":"70","author":"von Bernhardi","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.tips.2025.05.001_bb0350","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/glia.24426","article-title":"The committed oligodendrocyte precursor cell, a newly-defined intermediate progenitor cell type in oligodendroglial lineage","volume":"71","author":"Fang","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.tips.2025.05.001_bb0355","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1523\/JNEUROSCI.0898-16.2016","article-title":"Olig2-targeted G-protein-coupled receptor Gpr17 regulates oligodendrocyte survival in response to lysolecithin-induced demyelination","volume":"36","author":"Ou","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2025.05.001_bb0360","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/glia.22896","article-title":"The ubiquitin ligase Mdm2 controls oligodendrocyte maturation by intertwining mTOR with G protein-coupled receptor kinase 2 in the regulation of GPR17 receptor desensitization","volume":"63","author":"Fumagalli","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.tips.2025.05.001_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106315","article-title":"G protein-coupled receptor 17 is regulated by WNT pathway during oligodendrocyte precursor cell differentiation","volume":"187","author":"Boccazzi","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2025.05.001_bb0370","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3390\/cells11152369","article-title":"Rewiring of glucose and lipid metabolism induced by G protein-coupled receptor 17 silencing enables the transition of oligodendrocyte progenitors to myelinating cells","volume":"11","author":"Marangon","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.tips.2025.05.001_bb0375","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/glia.24356","article-title":"Analysis of the GPR17 receptor in NG2-glia under physiological conditions unravels a new subset of oligodendrocyte progenitor cells with distinct functions","volume":"71","author":"Miralles","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.tips.2025.05.001_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173486","article-title":"The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion","volume":"12","author":"Koenen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2025.05.001_bb0385","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1124\/mol.116.107904","article-title":"The orphan receptor GPR17 is unresponsive to uracil nucleotides and cysteinyl leukotrienes","volume":"91","author":"Simon","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2025.05.001_bb0390","doi-asserted-by":"crossref","first-page":"W260","DOI":"10.1093\/nar\/gkz303","article-title":"NGPhylogeny.fr: new generation phylogenetic services for non-specialists","volume":"47","author":"Lemoine","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2025.05.001_bb0395","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/bioinformatics\/btq243","article-title":"The Newick utilities: high-throughput phylogenetic tree processing in the UNIX shell","volume":"26","author":"Junier","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tips.2025.05.001_bb0400","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/molbev\/mst010","article-title":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability","volume":"30","author":"Katoh","year":"2013","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.tips.2025.05.001_bb0405","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2148-10-210","article-title":"BMGE (Block Mapping and Gathering with Entropy): a new software for selection of phylogenetic informative regions from multiple sequence alignments","volume":"10","author":"Criscuolo","year":"2010","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.tips.2025.05.001_bb0410","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/sysbio\/syq010","article-title":"New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0","volume":"59","author":"Guindon","year":"2010","journal-title":"Syst. Biol."},{"key":"10.1016\/j.tips.2025.05.001_bb0415","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41586-018-0043-0","article-title":"Renewing Felsenstein's phylogenetic bootstrap in the era of big data","volume":"556","author":"Lemoine","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.05.001_bb0420","doi-asserted-by":"crossref","first-page":"W78","DOI":"10.1093\/nar\/gkae268","article-title":"Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool","volume":"52","author":"Letunic","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2025.05.001_bb0425","doi-asserted-by":"crossref","first-page":"D425","DOI":"10.1093\/nar\/gkae1065","article-title":"GPCRdb in 2025: adding odorant receptors, data mapper, structure similarity search and models of physiological ligand complexes","volume":"53","author":"Herrera","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2025.05.001_bb0430","unstructured":"Kostenis, E. et al. Rheinische Friedrich-Wilhelms-Universit\u00e4t Bonn. GPR17 agonists and screening assay, EP 2 567 698 A1"},{"key":"10.1016\/j.tips.2025.05.001_bb0435","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1021\/jm00173a003","article-title":"3-(2-carboxyindol-3-yl)propionic acid derivatives: antagonists of the strychnine-insensitive glycine receptor associated with the N-methyl-D-aspartate receptor complex","volume":"33","author":"Salituro","year":"1990","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2025.05.001_bb0440","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ijbiomac.2017.08.088","article-title":"Identification of novel GPR17-agonists by structural bioinformatics and signaling activation","volume":"106","author":"Saravanan","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.tips.2025.05.001_bb0445","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.3390\/cells10081975","article-title":"Alkylaminophenol and GPR17 agonist for glioblastoma therapy: a combinational approach for enhanced cell death activity","volume":"10","author":"Doan","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.tips.2025.05.001_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231483","article-title":"Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: a novel disease-modifying strategy for multiple sclerosis","volume":"15","author":"Parravicini","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2025.05.001_bb0455","doi-asserted-by":"crossref","first-page":"C1028","DOI":"10.1152\/ajpcell.00658.2008","article-title":"Functional characterization of two isoforms of the P2Y-like receptor GPR17: 35SGTPgammaS binding and electrophysiological studies in 1321N1 cells","volume":"297","author":"Pugliese","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.tips.2025.05.001_bb0460","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.cell.2019.04.044","article-title":"Illuminating G-protein-coupling selectivity of GPCRs","volume":"177","author":"Inoue","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tips.2025.05.001_bb0465","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1074\/jbc.M115.683953","article-title":"The orphan G protein-coupled receptor GPR17 negatively regulates oligodendrocyte differentiation via G\u03b1i\/o and its downstream effector molecules","volume":"291","author":"Simon","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2025.05.001_bb0470","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s12264-020-00495-6","article-title":"EPAC negatively regulates myelination via controlling proliferation of oligodendrocyte precursor cells","volume":"36","author":"Gao","year":"2020","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.tips.2025.05.001_bb0475","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/35055027","article-title":"Identification of XAF1 as an antagonist of XIAP anti-caspase activity","volume":"3","author":"Liston","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tips.2025.05.001_bb0480","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.neuropharm.2015.04.024","article-title":"The roles of extracellular related-kinases 1 and 2 signaling in CNS myelination","volume":"110","author":"Gonsalvez","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2025.05.001_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100881","article-title":"Human GPR17 missense variants identified in metabolic disease patients have distinct downstream signaling profiles","volume":"297","author":"Conley","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2025.05.001_bb0490","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1124\/pharmrev.121.000302","article-title":"\u03b2-arrestins: structure, function, physiology, and pharmacological perspectives","volume":"75","author":"Wess","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tips.2025.05.001_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/14737175.2016.1116387","article-title":"Remyelination strategies in multiple sclerosis: a critical reflection","volume":"16","author":"Kipp","year":"2016","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.tips.2025.05.001_bb0500","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrd.2017.115","article-title":"Remyelination therapies: a new direction and challenge in multiple sclerosis","volume":"16","author":"Plemel","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2025.05.001_bb0505","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.stem.2020.03.017","article-title":"Problems and pitfalls of identifying remyelination in multiple sclerosis","volume":"26","author":"Neumann","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tips.2025.05.001_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.molpha.2025.100027","article-title":"Enhancing remyelination in multiple sclerosis via M1 muscarinic acetylcholine receptor","volume":"107","author":"Chen","year":"2025","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2025.05.001_bb0515","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mds.30144","article-title":"Effects of montelukast on neuroinflammation in Parkinson's disease: an open label safety and tolerability trial with CSF markers and 11CPBR28 PET","volume":"40","author":"Wallin","year":"2025","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tips.2025.05.001_bb0520","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0006-8993(96)01065-7","article-title":"The glycine site of the NMDA receptor contributes to neurokinin1 receptor agonist facilitation of NMDA receptor agonist-evoked activity in rat dorsal horn neurons","volume":"744","author":"Heppenstall","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.tips.2025.05.001_bb0525","doi-asserted-by":"crossref","first-page":"10908","DOI":"10.1021\/acs.jmedchem.1c00277","article-title":"Synthesis and preclinical validation of novel indole derivatives as a GPR17 agonist for glioblastoma treatment","volume":"64","author":"Nguyen","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2025.05.001_bb0530","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jacbts.2017.04.002","article-title":"P2Y12 receptor function and response to cangrelor in neonates with cyanotic congenital heart disease","volume":"2","author":"Kaza","year":"2017","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.tips.2025.05.001_bb0535","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/j.1476-5381.2009.00454.x","article-title":"P2Y(1) receptors mediate inhibitory neuromuscular transmission in the rat colon","volume":"158","author":"Grasa","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2025.05.001_bb0540","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/21658","article-title":"Characterization of the human cysteinyl leukotriene CysLT1 receptor","volume":"399","author":"Lynch","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.05.001_bb0545","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1038\/s41467-019-13348-2","article-title":"Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors","volume":"10","author":"Gusach","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2025.05.001_bb0550","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1124\/jpet.111.186031","article-title":"A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia\/reperfusion injury and vascular permeability in mice","volume":"339","author":"Ni","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2025.05.001_bb0555","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1476-5381.2010.00730.x","article-title":"Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor","volume":"160","author":"Wunder","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2025.05.001_bb0560","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae178","article-title":"Scoring alignments by embedding vector similarity","volume":"25","author":"Ashrafzadeh","year":"2024","journal-title":"Brief. Bioinform."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614725000914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614725000914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:52:04Z","timestamp":1777495924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614725000914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":112,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0165614725000914"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2025.05.001","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GPR17 \u2013 orphan G protein-coupled receptor with therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2025.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}